Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HIV-1

Known as: human immunodeficiency virus type 1, HIV-1, Immunodeficiency Virus Type 1, Human, human immunodeficiency virus-1 HIV-1 
The type species of lentivirus and the etiologic agent of acquired immunodeficiency syndrome (AIDS). It is characterized by its cytopathic effect and… Expand
National Institutes of Health

Related topics

Related topics

48 relations
Acquired Immunodeficiency SyndromeCDISC SDTM Microorganism TerminologyCDISC SDTM Species TerminologyClinical Data Interchange Standards Consortium Terminology
Expand

Broader (1)

HIV

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
BACKGROUND An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy… Expand
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.
BACKGROUND In the RV144 trial, the estimated efficacy of a vaccine regimen against human immunodeficiency virus type 1 (HIV-1… Expand
  • table 1
  • figure 3
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
BACKGROUND Antiretroviral preexposure prophylaxis is a promising approach for preventing human immunodeficiency virus type 1 (HIV… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Macrophages and dendritic cells have key roles in viral infections, providing virus reservoirs that frequently resist antiviral… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.
BACKGROUND The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is critical to… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1
Human immunodeficiency virus type 1 (HIV-1), the cause of human acquired immunodeficiency syndrome (AIDS), is a zoonotic… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
The human AIDS viruses human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) represent cross-species (zoonotic… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Decay characteristics of HIV-1-infected compartments during combination therapy
Analysis of changes in viral load after initiation of treatment with potent antiretroviral agents has provided substantial… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus*
Tat is an 86-amino acid protein involved in the replication of human immunodeficiency virus type 1 (HIV-1). Several studies have… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
Recent studies have identified several coreceptors that are required for fusion and entry of Human Immunodeficiency Virus type 1… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE